by Cailley LaPara | Sep 20, 2022
The economy may be ailing but dominant healthcare stocks have so far resisted infection, and look poised to continue thriving. Pharmacy retailer and insurer CVS (CVS) closed Friday at $102 per share, just about where it began the year. Leading drug manufacturer Eli...
by Vita Dadoo Lomeli | Sep 20, 2022
By Vita Dadoo The Inflation Reduction Act has created more buzz around an already trendy renewable energy source — solar — while still leaving plenty of room to ride in the long-term. Solar stocks, which include companies in the energy, utilities, and...
by James O'Donnell | Sep 20, 2022
Investors dismayed by the market’s dramatic decline and global rate hike uncertainty may find a remedy in resilient health insurer stocks. Over the past six months, shares in Cigna, UnitedHealth and Elevance Health have all gained as the S&P 500 has...
by Andre Beganski | Sep 20, 2022
Despite billions of dollars for chip plants built in the U.S. and a lucrative tax credit, investor demand for semiconductor stocks has short circuited amid the CHIPS and Science Act. Nvidia (NVDA) has been hit hardest, down 55% on the year, after closing Friday at...
by Molly Boigon | Sep 20, 2022
Oil and gas prices are dropping, but investors are rushing to buy oil and gas stocks anyway, a sign that they’re betting energy pain in Europe and the coming winter will boost demand and return prices to their earlier highs. Exxon Mobil Corp, Chevron Corporation and...
by Lucy Papachristou | Sep 20, 2022
By Lucy Papachristou Federal legislative overhaul of the healthcare sector is throwing a wrench into Big Pharma’s growth this fall, but companies are expected to weather the storm in a market hungry for new drug therapies. Stocks of insulin producers Eli...